Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MNSFbeta
is a ubiquitously expressed member of the ubiquitin-like family that has been implicated in various biological functions. Previous studies have demonstrated that
MNSFbeta
covalently binds to intracellular proapoptotic protein Bcl-G in mitogen-activated murine T cells. In this study, we further investigated the intracellular mechanism of action of
MNSFbeta
in macrophage cell line, Raw 264.7 cells. We present evidence that
MNSFbeta
.Bcl-G complex associates with ERKs in non-stimulated Raw 264.7. We found that
MNSFbeta
.Bcl-G directly bound to ERKs and inhibited ERK activation by
MEK1
. In Raw 264.7 cells treated with
MNSFbeta
small interfering RNA (siRNA) lipopolysaccharide (LPS)-induced ERK1/2 activation was enhanced and LPS-induced JNK and p38 activation was unaffected. SiRNA-mediated knockdown of
MNSFbeta
increased tumor necrosis factor alpha (TNFalpha) expression at mRNA and protein levels in LPS-stimulated Raw 264.7 cells. Finally, we found that transfection with
MNSFbeta
expression construct resulted in a significant inhibition of LPS-induced ERK activation and TNFalpha production. Co-transfection experiments with
MNSFbeta
and Bcl-G greatly enhanced this inhibition. Collectively, these findings indicate that
MNSFbeta
might be implicated in the macrophage response to LPS.
...
PMID:The ubiquitin-like protein MNSFbeta regulates ERK-MAPK cascade. 1662 90